Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the audited standalone and ....
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hester Biosciences has informed BSE and NSE that its Board of Directors meeting is scheduled for 15 May 2026. The meeting will consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026. Additionally, the Board will consider declaring a dividend on equity shares for financial year 2025-26. This filing is made under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates advance intimation of board meetings that may impact security prices.
This is a routine regulatory intimation. The actual impact on the stock will depend on the financial results and dividend announcement. If a dividend is declared, it could provide positive sentiment. Investors should wait for the actual results on or after 15 May 2026.